PlainRecalls
FDA Drug Moderate Class II Ongoing

Isotretinoin Capsules, USP 40mg, 30-count 3x10 blister packs per carton, Rx Only, Manufactured For: Teva Pharmaceuticals USA, Inc., Parsippany, NJ 07054. Blister Pack NDC 0591-2436-45, Carton NDC 0591-2436-15

Reported: April 17, 2024 Initiated: March 28, 2024 #D-0439-2024

Product Description

Isotretinoin Capsules, USP 40mg, 30-count 3x10 blister packs per carton, Rx Only, Manufactured For: Teva Pharmaceuticals USA, Inc., Parsippany, NJ 07054. Blister Pack NDC 0591-2436-45, Carton NDC 0591-2436-15

Reason for Recall

Superpotent Drug: The 3-month stability result for assay was found to be above specification limit

Details

Units Affected
5,304 3x10-cartons
Distribution
Nationwide in the USA
Location
Parsippany, NJ

Frequently Asked Questions

What product was recalled?
Isotretinoin Capsules, USP 40mg, 30-count 3x10 blister packs per carton, Rx Only, Manufactured For: Teva Pharmaceuticals USA, Inc., Parsippany, NJ 07054. Blister Pack NDC 0591-2436-45, Carton NDC 0591-2436-15. Recalled by Teva Pharmaceuticals USA, Inc. Units affected: 5,304 3x10-cartons.
Why was this product recalled?
Superpotent Drug: The 3-month stability result for assay was found to be above specification limit
Which agency issued this recall?
This recall was issued by the FDA Drug on April 17, 2024. Severity: Moderate. Recall number: D-0439-2024.